期刊文献+

原发性帕金森病患者检测血尿酸的意义 被引量:4

下载PDF
导出
摘要 目的分析原发性帕金森病患者的血浆尿酸水平,并探讨血浆尿酸水平与帕金森病认知功能损害的关系。方法收集2012-2014年诊断为帕金森病患者46例设为帕金森病组,并进行MMSE量表测定,根据结果再分为认知障碍组与非认知障碍组;同时收集体检中心与帕金森组性别、年龄、教育程度相匹配的健康体检人员作为对照组(46例)。2组均检测空腹静脉血浆尿酸值,并对结果进行统计学分析。结果帕金森病组血尿酸水平明显低于对照组(P<0.05);认知障碍组血尿酸水平低于非认知障碍组及对照组(P<0.05)。结论帕金森病患者血尿酸水平降低,提示血尿酸水平与帕金森病的发病有密切关系,且与帕金森病认知损害有关。
出处 《淮海医药》 CAS 2015年第6期561-562,共2页 Journal of Huaihai Medicine
  • 相关文献

参考文献16

二级参考文献81

  • 1姚庆和,高国栋.肌苷对帕金森病小鼠模型的神经保护作用[J].第四军医大学学报,2005,26(2):141-145. 被引量:20
  • 2Ma L Zhang L Gao XH Chen W Wu YP Wang Y Li XF Como P Kieburtz K Qiao YL.Dietary factors and smoking as risk factors for PD in a rural population in China: a nested case-control study[J].中国生物学文摘,2006,20(8):7-8. 被引量:13
  • 3蔡晓杰,陈海波,王新德,贡慧华.帕金森病患者的智能障碍—瑞文测验的应用及意义[J].脑与神经疾病杂志,1997,5(2):94-96. 被引量:13
  • 4Lieberman A.Are dementia and depression in Parkinson's disease related? J Neurol Sci,2006,248:138-142.
  • 5de Lau LM,Koudstaal PJ,Hofman A,et al.Serum uric acid levels and the risk of Parkinson disease.Ann Neurol,2005,58:797-800.
  • 6Weisskopf MG,O'Reilly E,Chen H,et al.Plasma urate and risk of Parkinson's disease.Am J Epidemiol,2007,166:561-567.
  • 7Meara J,Bhownick BK,Hobson P.Accuracy of diagnosis in patients with presumed Parkinson's disease.Age Ageing,1999,28:99-102.
  • 8Farr SA,Poon HF,Dogrukol-AkD,et al.The antioxidants alpha-lipoic acid and N-acetylcysteine reverse memory impairment and antioxidative stress in aged SAMP8 mice.J Neurochem,2003,84:1173-1183.
  • 9Fukui K,Onodera K,Shinkai T.Impairment of learning and memory in rats caused by oxidative stress and aging,and changes in antioxidative defense systems.Ann NY Acad Sci,2001,928:168-175.
  • 10Luo WF,Schwarzschild MA,Xu K.Urate attenuates MPTP-induced dopmainergic toxicity in mice.The Society for neuroscience 37th annual meeting,2007.San Diego,California,USA.

共引文献63

同被引文献34

  • 1Hanrott K, Gudmunsen L, et al. 6-hydroxydopamine-induced apoptosis is mediated via extracellular auto-oxidation and caspase 3-dependent activation of protein kinase Cdelta[J]. The Journal of Biological Chemistry,2011,281(9) :5373-5382.
  • 2Guerreiro S,Ponceau A, Schwarzschild MA,et al. Protection of midbrain dopaminergic neurons by the end-product of purine metabolism uric acid: potentiation by low-level depolarizatio [J]. Journal of Neurochemistry, 2009,109 (4) : 1118-1128.
  • 3Lee DW, Rajagopalan S, Siddiq A, et al. Inhibition of prolyl hydroxylase protects against 1-methyl-4-phenyl-1,2,3, 6-tet- rahydropyridineqnduced neurotoxicity:model for the potential involvement of the hypoxiaqnducible factor pathway in Par- kinson disease[J]. J Biol Chem, 2009,284 (42) : 29065-29076.
  • 4Scott GS, Spitsin SV, et al. Therapeutic intervention in experi- mental allergic encephalomyelitis by administration of uric acd- precursors[J]. Proe Natl Acad Sci USA,2002,99(25):16303.
  • 5Davis JW, Grandinetti A, Waslien CI, et al. Observations on se- rum uric acid levels and the risk of idiopathic Parkinson disease [J]. Am J Epidemiol, 1996,144(5) :480-484.
  • 6Church WH,Ward VL. Uric acid is reduced in the substantia nigra in Parkinson disease: effect on dopamine oxidation[J]. Brain Res Bull, 1994,33 (4) : 419-425.
  • 7Chunhong Shen,Yi Guo,Wei Luo,Chen Lin,Meiping Ding.Serum Urate and the Risk of Parkinson’s Disease: Results From a Meta-Analysis. The Canadian Journal of Neurological Sciences . 2013
  • 8C. Marin,E. Aguilar,G. Mengod,R. Cortés,J. A. Obeso.Effects of early vs. late initiation of levodopa treatment in hemiparkinsonian rats. European Journal of Neuroscience . 2009
  • 9M. Moccia,M. Picillo,R. Erro,C. Vitale,K. Longo,M. Amboni,G. Santangelo,R. Palladino,G. Capo,G. Orefice,P. Barone,M. T. Pellecchia.??Presence and progression of non‐motor symptoms in relation to uric acid in de novo P arkinson’s disease(J)Eur J Neurol . 2015 (1)
  • 10Isabel González‐Aramburu,Pascual Sánchez‐Juan,Silvia Jesús,Ana Gorostidi,Eduardo Fernández‐Juan,Fátima Carrillo,María Sierra,Pilar Gómez‐Garre,María T. Cáceres‐Redondo,José Berciano,Javier Ruiz‐Martínez,Onofre Combarros,Pablo Mir,Jon Infante.??Genetic variability related to serum uric acid concentration and risk of Parkinson’s disease(J)Mov Disord. . 2013 (12)

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部